• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    With Fermion, start the journey of your innovative API.

    Kubota Announces Post Hoc Analysis from Phase 3 Clinical Trial of Emixustat

    BUSINESSWIRE

    Kubota Vision Announced End of PIII Trial of Emixustat in Stargardt Disease

    BUSINESSWIRE

    Kubota Vision Announces Publication of Emixustat’s Pharmacodynamic Effects

    BUSINESSWIRE

    Kubota Vision Receives Orphan Products Clinical Trials Grants to Emixustat

    BUSINESSWIRE

    Kubota Vision Completes Enrollment in the Emixustat Ph 3 Trial

    BUSINESSWIRE

    Acucela Announces Publication Assessing the Role of Emixustat Hydrochloride

    BUSINESS WIRE

    Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.